ABCG2 and gout: The percentage of males might be a potential source of heterogeneity in the effects of ABCG2 and SLC2A9 on gout, since the risk or protective effects were consistently stronger in men; this may indicate sex-specific differences in pathological mechanisms or in the handling of urate.